IONS
Ionis Pharmaceuticals Inc.
Latest News for IONS
In a report released yesterday, William Pickering from Bernstein maintained a Hold rating on Ionis Pharmaceuticals, with a price target of $65.00. ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ionis Pharmaceuticals (IONS – Research Report) and I......
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Thursday, November 6, according to daily fund d......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ionis Pharmaceuticals (IONS – Research Report) and......
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) revealed several key portfolio moves for Monday, October 27, 2025, signaling stronger convict......
Ionis Pharmaceuticals Inc. (($IONS)) announced an update on their ongoing clinical study. Ionis Pharmaceuticals Inc. is conducting a clinical study......
Oppenheimer analyst Jay Olson maintained a Buy rating on Ionis Pharmaceuticals today and set a price target of $90.00. The company’s shares closed ......
Ionis Pharmaceuticals Inc. (($IONS)) announced an update on their ongoing clinical study. Study Overview: The Orbit Study, officially titled ‘A Pha......
In a report released today, William Pickering from Bernstein maintained a Hold rating on Ionis Pharmaceuticals, with a price target of $50.00. The ......
News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IONS | $76.09 | +4.1% | 2.08M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ionis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW